We're proud to now offer improved treatment for men receiving radiation therapy for prostate cancer.
Traditionally, radiation therapy in the treatment of prostate cancer can cause unintended radiation injury to adjacent healthy tissue leading to a range of bowel, urinary, and sexual symptoms that can negatively affect patient health and quality of life during radiotherapy, and for years afterwards.
SpaceOAR lowers the risk of unwanted side effects, using hydrogel to reduce the radiation dose delivered to unwanted areas and the risk of injury. The hydrogel is placed on surrounding tissue to protect the area for approximately three months during radiation therapy, then liquefies and is completely absorbed by the body.
In a clinical study, SpaceOAR hydrogel demonstrated a 99 percent procedural success rate, a 73.5 percent reduction in radiation dose to healthy tissue, and significantly less impact on life.